ArticleBMC cardiovascular disorders2025

High-sensitivity c-reactive protein and cardiovascular disease risk assessment in a population of type 2 diabetes mellitus patients.

Bruno Basil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.